Opinion

Video

Future Perspectives in KRAS G12C-Mutated NSCLC

In closing, experts share future perspectives in KRAS G12C-mutated NSCLC, emphasizing novel targeted therapies and emerging trials in the evolving treatment landscape.

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
Dr Cascone on Evaluating Neoadjuvant Durvalumab-Based Regimens in Resectable NSCLC